• Veteran ‘Lord of the Flies’ Takes a Crack at Addiction

    Jun 12 | Bio-IT World | The brain of fruit flies and humans may be vastly different in size and complexity, but at the circuit level they are not all that different, according to a veteran fly geneticist who has spent much of his career trying to understand why humans abuse drugs. An interest in alcohol dependence segued to another major health problem, cocaine abuse disorder, which has some of the same genetic underpinnings. More

  • NVIDIA, Novo Nordisk Collaborate to Bring AI Agents to Drug Discovery

    Jun 11 | Bio-IT World | Today, NVIDIA announced a collaboration with Novo Nordisk to accelerate drug discovery efforts by creating customized AI models and agents that Novo Nordisk can use for early research and clinical development and to apply advanced simulation and physical AI technologies. More

  • A Farewell to Stan Gloss: Leading with Generosity and Other Words of Wisdom

    Jun 10 | Bio-IT World | BioTeam co-founder and host of Trends from the Trenches Stan Gloss is passing the torch to BioTeam CEO Ari Berman. Gloss founded BioTeam with William van Etten, Chris Dagdigian, and Michael Athanas 22 years ago and built an organization that focuses on helping scientists find solutions, manage data, and accelerate scientific innovation. In his last episode of Trends from the Trenches, Gloss is interviewed by Berman to discuss the founding of BioTeam and words of wisdom for those who are starting their own company. More

  • MIT Researchers Unveil Boltz-2: AI Model Predicts Protein Structure, Binding Affinity in Seconds

    Jun 06 | Bio-IT World | Researchers at MIT and Recursion today announced the release of Boltz-2, an updated artificial intelligence model that can predict protein structure (building on Boltz-1) and also binding affinity—how strongly potential drugs bind to their target proteins—in just 20 seconds with a single GPU. More

  • Smart Bandage Merges Sensor Technology, Microfluidics, and AI

    Jun 04 | Bio-IT World | California Institute of Technology researchers have successfully integrated multiple biotechnologies to create the world's first clinically-tested smart bandage system. The iCares smart bandage represents a remarkable fusion of three rapidly advancing biotechnology fields: wearable sensor technology, microfluidics engineering, and machine learning algorithms. More

  • A Practical Precision Medicine Approach to Complex Chronic Diseases

    Jun 03 | Bio-IT World | Although not often counted among the major chronic diseases, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are both highly prevalent and uniquely challenging because the underlying causes are not fully understood, treatment needs to be personalized, and the often-invisible nature of the symptoms can be stigmatizing. More

  • Follow the Money: Pathos AI Drug Development Platform, Stylus Medicine’s In Vivo Advancements, More

    May 30 | Bio-IT World | Pathos AI plans to continue investment in their AI foundation model for oncology; Stylus Medicine is emerging from stealth and advancing the company’s in vivo genetic medicines platform and pipeline of in vivo therapeutic programs; and more. More

  • Illumina’s Newest DRAGEN, Lupus Research Alliance Launches Dataset, More

    May 29 | Bio-IT World | Illumina announced the launch of DRAGEN version 4.4 software; Lupus Research Alliance (LRA) announced the launch of the Lupus Nexus Foundational Analyses; and more. More

  • The ALL ALS Consortium’s Open Science Initiative

    May 27 | Bio-IT World | The Access for All in ALS (ALL ALS) Consortium is spearheading an ambitious open science initiative that aims to transform how we understand and treat this devastating neurological disease. Led by Robert Bowser, Ph.D. of the Barrow Neurological Institute and James Berry, M.D. of Massachusetts General Hospital, the consortium is conducting two studies: ASSESS for people living with ALS and healthy controls and PREVENT for those with genetic risk factors but no symptoms. More

  • CURATE.AI: How Digital Twins Are Revolutionizing Precision Dosing

    May 22 | Bio-IT World | Singapore researchers have developed an innovative artificial intelligence platform that creates personalized “digital twins” of patients to optimize drug dosing on an individual basis. The CURATE.AI platform, developed by Dr. Dean Ho and his team at the National University of Singapore's Institute for Digital Medicine (WisDM), represents a significant advancement in precision medicine by dynamically adjusting treatment regimens based on real-time patient responses. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!